69 related articles for article (PubMed ID: 22209841)
1. Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer.
Liu C; Zhou X; Gao F; Qi Z; Zhang Z; Guo Y
Cancer Gene Ther; 2015 Jun; 22(6):312-6. PubMed ID: 26065377
[TBL] [Abstract][Full Text] [Related]
2. Immuno-expression of endoglin and smooth muscle actin in the vessels of brain metastases. Is there a rational for anti-angiogenic therapy?
Barresi V; Branca G; Caffo M; Caltabiano R; Ieni A; Vitarelli E; Lanzafame S; Tuccari G
Int J Mol Sci; 2014 Apr; 15(4):5663-79. PubMed ID: 24699047
[TBL] [Abstract][Full Text] [Related]
3. Prolonged activity of bevacizumab in adenocarcinoma of the lung with multiple brain metastases.
Danciu OC; Rayani S; Michals EA; Villano JL
Med Oncol; 2012 Dec; 29(4):2619-22. PubMed ID: 22209841
[TBL] [Abstract][Full Text] [Related]
4. Targeting angiogenesis for treatment of NSCLC brain metastases.
Schettino C; Bareschino MA; Rossi A; Maione P; Sacco PC; Colantuoni G; Rossi E; Gridelli C
Curr Cancer Drug Targets; 2012 Mar; 12(3):289-99. PubMed ID: 22229249
[TBL] [Abstract][Full Text] [Related]
5. [Long-term survival of a patient with advanced non-small cell lung cancer on bevacizumab therapy: case report and review of the literature].
Wu W; Tang J; Wu Y; Zhu Y; Xu L; Shi H; Meng Q; Liu Z; Guo L; Tao H; Li M; Liu Z
Zhongguo Fei Ai Za Zhi; 2013 Jun; 16(6):325-9. PubMed ID: 23769349
[TBL] [Abstract][Full Text] [Related]
6. Complete regression of a non-small cell lung cancer choroidal metastasis with intravitreal bevacizumab.
D'Antonio C; Viterbo A; Romiti A; Enrici MM; Lauro S; Marchetti P
J Thorac Oncol; 2012 Feb; 7(2):468-9. PubMed ID: 22252564
[No Abstract] [Full Text] [Related]
7. Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC).
Schmid-Bindert G
Target Oncol; 2013 Mar; 8(1):15-26. PubMed ID: 23371029
[TBL] [Abstract][Full Text] [Related]
8. Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer.
Heist RS; Duda DG; Sahani DV; Ancukiewicz M; Fidias P; Sequist LV; Temel JS; Shaw AT; Pennell NA; Neal JW; Gandhi L; Lynch TJ; Engelman JA; Jain RK
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1547-52. PubMed ID: 25605928
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer.
De Braganca KC; Janjigian YY; Azzoli CG; Kris MG; Pietanza MC; Nolan CP; Omuro AM; Holodny AI; Lassman AB
J Neurooncol; 2010 Dec; 100(3):443-7. PubMed ID: 20440540
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab safety in patients with central nervous system metastases.
Besse B; Lasserre SF; Compton P; Huang J; Augustus S; Rohr UP
Clin Cancer Res; 2010 Jan; 16(1):269-78. PubMed ID: 20028762
[TBL] [Abstract][Full Text] [Related]
11. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla.
Larsson HB; Courivaud F; Rostrup E; Hansen AE
Magn Reson Med; 2009 Nov; 62(5):1270-81. PubMed ID: 19780145
[TBL] [Abstract][Full Text] [Related]
12. Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases.
Socinski MA; Langer CJ; Huang JE; Kolb MM; Compton P; Wang L; Akerley W
J Clin Oncol; 2009 Nov; 27(31):5255-61. PubMed ID: 19738122
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Friedman HS; Prados MD; Wen PY; Mikkelsen T; Schiff D; Abrey LE; Yung WK; Paleologos N; Nicholas MK; Jensen R; Vredenburgh J; Huang J; Zheng M; Cloughesy T
J Clin Oncol; 2009 Oct; 27(28):4733-40. PubMed ID: 19720927
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]